SCHEMBL3873285

SCHEMBL3873285

O=C(c1cc(F)cc(CNS(=O)(=O)c2ccc(-c3ccccc3)cc2)c1)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ GAA P10253 2/20 0.54
▸ HSD11B1 P28845 1/20 0.53
▸ HPGD P15428 4/20 0.53
▸ HTT P42858 3/20 0.53
▸ CASP1 P29466 1/20 0.53
▸ CASP7 P55210 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ CYP1A2 P05177 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ RAB9A P51151 3/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PKM P14618 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3875225 0.94 HPGD (0.59) ALDH1A1GAAHSD11B1HPGDHTT
SCHEMBL4026873 0.88 HSD11B1 (0.53) ALDH1A1HSD11B1HPGDHTTHSD17B10
SCHEMBL3882866 0.87 RAB9A (0.62) ALDH1A1GAAHSD11B1HPGDHTT
SCHEMBL3874946 0.82 GPR55 (0.53) GAACYP1A2
SCHEMBL3875212 0.78 POLB (0.53) ALDH1A1GAACYP1A2POLBSMN1; SMN2
SCHEMBL3873492 0.77 RAB9A (0.76) ALDH1A1HSD11B1HPGDHTTCYP1A2
SCHEMBL3887286 0.77 RAB9A (0.60) ALDH1A1GAAHSD11B1HPGDHTT
SCHEMBL3874296 0.77 SMN1; SMN2 (0.62) ALDH1A1GAAHSD11B1HPGDHTT
SCHEMBL3873960 0.76 PKM (0.74) ALDH1A1HSD11B1HPGDHTTCYP1A2
SCHEMBL3872124 0.76 CYP19A1 (0.55) GAAHPGDCYP1A2POLBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814846-B1 11BETA-HSD1 INHIBITORS EVOTEC AG (DE) 2009-04-08 — — EP disclosed
US-20090069323-A1 11beta-hsdi inhibitors EVOTEC AG (DE) 2009-03-12 — — US disclosed
EP-1814846-A1 11BETA-HSD1 INHIBITORS Evotec AG (DE) 2007-08-08 — — EP disclosed
WO-2006048330-A1 11ΒΕΤΑ-HSD1 INHIBITORS EVOTEC AG (DE) 2006-05-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069323-A1 11beta-hsdi inhibitors HSD3B1, HSD3B2, HSD11B1 ALDH1A1 210/4885GAA 2618/4885HSD11B1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback